Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.

about

Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics.Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors.Transthyretin Mimetics as Anti-β-Amyloid Agents: A comparison of peptide and protein approaches.

P2860

Q38881147-50173933-802C-42B3-A63A-DA7E6F852313 Q47780004-817BAD30-410A-40D3-8EF8-D5BD733B727A Q51735672-C2468F5A-EF63-4DBF-B326-724481143B00

P2860

Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.

Item

http://www.wikidata.org/entity/Q38558352

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.

@en

type

Item

label

Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.

@en

prefLabel

Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.

@en

P1476

Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.

@en

P2093

Pankaj Mishra

http://www.w3.org/2001/XMLSchema#string

Senthil R Ayyannan

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus

A comparative analysis of the aggregation behavior of amyloid-β peptide variants

Molecular basis for passive immunotherapy of Alzheimer's disease

Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core

Stabilization of a -hairpin in monomeric Alzheimer's amyloid- peptide inhibits amyloid formation

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease

A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR

P304

1467-1474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201500215

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gautam Panda

P577

2015-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280490777

http://www.w3.org/2001/XMLSchema#string

P698

26230674

http://www.w3.org/2001/XMLSchema#string

Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.

about

P2860

P2860

Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698